Computational modelling reveals advantages of ventricular over atrial cardiomyocytes to power self-guided biorobots

Imagine a world where tiny, living machines could swim through your bloodstream, hunting down a tumor like a bloodhound tracking a scent, and then release medicine right at the source. This isn't science fiction; it's the frontier of "biorobotics." Scientists are trying to build robots that aren't made of metal and gears, but of living cells. The big idea is to use cells that naturally want to move or contract—like heart muscle cells—to power these tiny devices. Why does this matter? Because giving medicine to a sick person usually means flooding their whole body with drugs, which can hurt healthy parts. If a robot could find the sick spot on its own, it could deliver the cure exactly where it's needed, saving the rest of the body from the side effects. But there's a catch: these robots need to be smart enough to find their way and strong enough to move without needing a human to push them with magnets or lasers from the outside.

This paper dives into a computer simulation to solve a specific puzzle: which kind of heart cell makes the best engine for these tiny robots? The researchers built a virtual, H-shaped robot made of soft silicone arms and a gold bar, covered in living heart cells. They wanted to see if the robot moved better if the cells came from the upper chambers of the heart (the atria) or the lower, harder-working chambers (the ventricles). They also tested if the robot could steer itself toward areas with less oxygen, which is a common sign of a tumor. By running thousands of virtual races, they discovered that the type of cell matters more than anyone thought. The "ventricular" cells, which are naturally stronger, made the robot zoom along much faster and turn more sharply than the "atrial" cells, all while using the same amount of energy. It turns out that picking the right biological part is just as important as designing the robot's shape.

The Robot Race: Heart Cells vs. Heart Cells

Think of this study like a high-tech car race, but instead of engines, the cars are powered by tiny living heart cells. The researchers created a virtual robot shaped like the letter "H." It has two long arms made of a soft, stretchy material (like a very stretchy rubber band) and a stiff gold bar connecting them in the middle. To make this robot move, they glued thousands of newborn rat heart cells onto the arms. These cells have a superpower: they naturally squeeze and relax, just like your heart beats.

To turn that squeezing into forward motion, the robot uses a clever trick called a "friction ratchet." Imagine an earthworm or a snake moving across the ground. They have tiny scales that grip the ground tightly when they push backward but slide easily when they push forward. This robot mimics that. As the heart cells squeeze, they create a wave of movement that travels down the arm. Because the robot grips the ground better in one direction than the other, every squeeze pushes it a tiny bit forward.

The scientists ran a massive simulation to see how two different types of heart cells would perform in this robot. They compared atrial cells (from the top chambers of the heart) against ventricular cells (from the bottom chambers). In the real body, ventricular cells are the heavy lifters; they pump blood to the whole body, so they are built to be stronger. Atrial cells just pump blood a short distance to the lungs, so they are a bit more relaxed.

The results were a landslide victory for the ventricular cells. In the straight-line race, the robot powered by ventricular cells moved 4.35 times faster than the one powered by atrial cells. That's like a sprinter beating a casual jogger by a huge margin. Even more impressive, they didn't just go faster; they were just as efficient. The "cost of transport"—which is basically how much energy it takes to move a certain distance—was almost the same for both. The ventricular robot got a massive speed boost without burning extra fuel.

Steering by Smell: The Oxygen Compass

The second part of the experiment was even cooler. The researchers wanted to see if the robot could steer itself. Tumors and other sick tissues often have low oxygen levels (hypoxia). The scientists programmed the robot to sense oxygen. If one side of the robot sensed less oxygen than the other, it would slow down that side, causing the robot to turn toward the "scent" of the low-oxygen area.

When they turned on the steering, the ventricular robot didn't just go faster; it turned better, too. It changed its direction 2.91 times more effectively than the atrial robot. Why? Because the ventricular cells were stronger, the difference in power between the left and right sides created a sharper turn. It's like having a car with a powerful engine on one side and a weak one on the other; the strong side pulls the car around the corner much more decisively.

What This Means for the Future

The paper doesn't claim these robots are ready to be injected into patients tomorrow. These results come from a computer model, a virtual world where the rules are perfect and the friction is just right. The researchers admit that in the real, messy world of the human body, things might be a bit different. However, the simulation proves a vital point: the choice of cell type is a "design variable" that engineers can tweak.

For a long time, scientists might have just picked whatever heart cells were easiest to get. This study suggests that if you want a fast, agile, self-guided robot, you should specifically choose the tough, strong ventricular cells. It's a bit like realizing that if you want a race car, you shouldn't just use any engine; you need the V8, not the four-cylinder.

The authors conclude that by treating the cell type as a design choice, we can build better bio-robots. These tiny machines could one day navigate the complex, low-oxygen tunnels of a tumor, delivering medicine directly to the cancer cells while leaving healthy tissue alone. While the robot in this story is currently just a digital dream, the lesson it teaches is real: in the world of living machines, the biology you choose is just as important as the engineering you build.